(Q46705002)

24 December 2017

title

Liposomal nanomedicines: an emerging field (English)

1 reference

24 December 2017

1 reference

3

Pieter R Cullis

1 reference

24 December 2017

author name string

David B Fenske

series ordinal

1

1 reference

24 December 2017

Arcadio Chonn

series ordinal

2

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

24 December 2017

published in

Toxicologic Pathology

1 reference

24 December 2017

volume

36

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

21-29

1 reference

24 December 2017

RNAi therapeutics: principles, prospects and challenges

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

The liposomal formulation of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Drug delivery systems: entering the mainstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Nanomedicine: techniques, potentials, and ethical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Targeted nanoparticle-based drug delivery and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Cationic liposome-mediated transfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Improved cationic lipid formulations for in vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Structural and motional properties of vesicles as revealed by nuclear magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Entrapment of small molecules and nucleic acid-based drugs in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Stabilized plasmid-lipid particles: a systemic gene therapy vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

RNA interference as a novel and powerful tool in immunopharmacological research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Bacterial DNA as immune cell activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

RNA interference: implications for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Developments in liposomal drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Vesicles of variable sizes produced by a rapid extrusion procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

RNA interference and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Stabilized plasmid-lipid particles for systemic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Programmed drug delivery: nanosystems for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Stabilized plasmid-lipid particles: construction and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

RNAi-mediated gene silencing in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310960

21 January 2018

Identifiers

DOI

10.1177/0192623307310960

1 reference

24 December 2017

1 reference

24 December 2017